Evidence map›Paper›PMID 41823184›Full record

ArticleACS biomaterials science & engineering2026

Implantation and Analysis of a Biphasic Bioinspired Osteochondral Chitosan Construct in a Large Animal Model.

Laura Macri Pellizzeri, Jane S McLaren, Reda Felfel, Katherine Pitrolino, Robert Kerslake, Colin Scotchford, David M Grant, Brigitte S Scammel, Virginie Sottile

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Laura Macri PellizzeriSchool of Medicine, University of Nottingham, Nottingham NG7 2UH, U.K.ORCID 0000-0002-0457-1869
Jane S McLarenSchool of Medicine, University of Nottingham, Nottingham NG7 2UH, U.K.
Reda FelfelAdvanced Materials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, U.K.
Katherine PitrolinoSchool of Medicine, University of Nottingham, Nottingham NG7 2UH, U.K.
Robert KerslakeSchool of Medicine, University of Nottingham, Nottingham NG7 2UH, U.K.
Colin ScotchfordAdvanced Materials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, U.K.
David M GrantAdvanced Materials Research Group, Faculty of Engineering, University of Nottingham, Nottingham NG7 2RD, U.K.
Brigitte S ScammelSchool of Medicine, University of Nottingham, Nottingham NG7 2UH, U.K.
Virginie SottileDepartment of Molecular Medicine, University of Pavia, Pavia 27100, Italy.ORCID 0000-0002-6064-5738

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteochondral defects are severe degenerative lesions of the joint that involve the articular cartilage, the cartilage-bone interface, and the underlying subchondral bone. Surgical approaches that have been developed (joint debridement, microfracture, autologous chondrocytes and autologous/allograft cartilage implantation, and whole joint replacement) remain, however, more palliative than curative. Therefore, novel strategies are required, including promising options offered by osteochondral tissue engineering approaches. In this study, a novel chitosan-based scaffold with biomimetic and biodegradable properties was implanted for 16 weeks in a sheep osteochondral defect model in order to evaluate its physical stability, biocompatibility, and regenerative potential. Alongside the chitosan construct, a commercial scaffold made of collagen and ß-TCP was implanted as a positive control, while defects left empty were used as negative control. Postoperative recovery and tissue response were evaluated at different levels including activity monitoring, gross tissue evaluation at sacrifice, imaging, and histological analysis. Despite a transient reaction observed in the first 4 weeks after implantation, the chitosan-based scaffold was well-tolerated, with no clear signs of local or systemic reaction in the long term. The chitosan scaffold was able to support the growth of mature bone tissue with a lamellar conformation at similar levels to the predicate control. It also promoted the formation of a new cartilage layer, although not at a fully mature stage. These proof-of-concept results suggest that the novel chitosan scaffold tested constitutes a possible option for osteochondral regeneration, which should be further analyzed in complementary models to provide information on its long-term performance.

Indexed as

Biocompatible MaterialsCartilage, ArticularChitosanTissue ScaffoldsAnimalsFemaleSheepTissue EngineeringBiocompatible MaterialsChitosanbiomateriallarge animal modelosteochondral repairregenerative medicinescaffold

Identifiers

PMID41823184
PMCPMC13080774

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.